CDD-3290

• Description:

  CDD-3290 (Compound 20) is a prostate-specific antigen (PSA) inhibitor with a Ki value of 216 nM. CDD-3290 also inhibits α-chymotrypsin and elastase[1].

• UNSPSC:

  12352005

• Target:

  Elastase; PSMA

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation; Metabolic Enzyme/Protease

• Field of Research:

  Others

• Assay Protocol:

  https://www.medchemexpress.com/cdd-3290.html

• Smiles:

  O=C(N1N=C(C2=CC=C(OC)N=C2)C=C1N)C3=CC=C(NC=N4)C4=C3

• Molecular Formula:

  C17H14N6O2

• Molecular Weight:

  334.33

• References & Citations:

  [1]Erickson J A, et al. Synthesis and Optimization of Small Molecule Inhibitors of Prostate Specific Antigen. ACS Medicinal Chemistry Letters, 2024.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported